

Cover Story
By Matthew Bin Han Ong
A federal judge has ruled against the Health Resources and Services Administration over provider access to 340B Drug Pricing Program discounts for orphan drugs.
By Matthew Bin Han Ong
In Brief


Funding Opportunities
Drugs & Targets


Trending Stories
- Mikaela Naylon Give Kids a Chance Act nixed by Senate
- Antonio Wolff, Mikala Egeblad named co-directors of Johns Hopkins Kimmel Cancer Center Breast and Gynecologic Cancer Program
- Twitter star Vinay Prasad retires @VinayPrasadMD
- 2025 in review: In a mess, there is movement—and leadership does matter
- A farewell post by an unidentified NCI employee triggers an accusation of “undermining the Trump administration”
- Dana-Farber to pay $15M to U.S. government in research fraud settlement











